Tang Capital Management as of March 31, 2021
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 11 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 31.6 | $112M | 2.5M | 44.37 | |
| Anaptysbio Inc Common (ANAB) | 15.9 | $57M | 2.6M | 21.55 | |
| Aptevo Therapeutics Com New | 15.1 | $54M | 1.8M | 30.52 | |
| Odonate Therapeutics Ord | 14.9 | $53M | 16M | 3.42 | |
| La Jolla Pharmaceuticl Com Par | 11.2 | $40M | 9.4M | 4.24 | |
| Vincerx Pharma Com New (VINC) | 2.7 | $9.7M | 500k | 19.30 | |
| Coherus Biosciences (CHRS) | 2.7 | $9.5M | 650k | 14.61 | |
| Relmada Therapeutics (RLMD) | 2.0 | $7.0M | 200k | 35.21 | |
| Bctg Acquisition Corp | 1.5 | $5.2M | 469k | 11.12 | |
| Equillium (EQ) | 1.2 | $4.3M | 600k | 7.15 | |
| Vincerx Pharma *w Exp 12/24/202 | 1.2 | $4.1M | 1.0M | 4.04 |
